BEGIN:VCALENDAR VERSION:2.0 PRODID:-//AUA Newsroom - ECPv6.2.9//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:AUA Newsroom X-ORIGINAL-URL:https://newsroom.aua.am X-WR-CALDESC:Events for AUA Newsroom REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:Asia/Yerevan BEGIN:STANDARD TZOFFSETFROM:+0400 TZOFFSETTO:+0400 TZNAME:+04 DTSTART:20210101T000000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=Asia/Yerevan:20210811T120000 DTEND;TZID=Asia/Yerevan:20210811T130000 DTSTAMP:20240329T053518 CREATED:20210809T082445Z LAST-MODIFIED:20210809T082445Z UID:42899-1628683200-1628686800@newsroom.aua.am SUMMARY:Challenges and Opportunities in Drug Development: Interdisciplinary Collaboration in Innovation DESCRIPTION:About the Event: \nDr. Ulf Hannelius will present advantages of interdisciplinary collaboration using tools from data sciences\, artificial intelligence\, and business administration\, with a focus on developing new drugs that can offer solutions to complex health problems and making them available for use. \nAbout the Speaker: \nUlf Hannelius earned his PhD in Molecular Biology from the Karolinska Institute in Stockholm where he also conducted his post-doctoral research in cancer genomics. He received an Executive MBA degree from Stockholm School of Economics. Dr. Hannelius has had experience in business development in the biotech and medtech industries prior to joining Diamyd Medical in 2015 where he has served as the CEO since 2016.    \nLanguage: English URL:https://newsroom.aua.am/event/challenges-and-opportunities-in-drug-development-interdisciplinary-collaboration-in-innovation/ LOCATION:Room 208E\, PAB\, American University of Armenia\, 40 Marshal Baghramyan Ave\, Yerevan\, Armenia CATEGORIES:Events Calendar,Health Sciences ATTACH;FMTTYPE=image/png:https://newsroom.aua.am/files/2021/08/CTHS_ULF_Hannelius.png ORGANIZER;CN="Turpanjian College of Health Sciences (CHS)":MAILTO:mphinfo@aua.am, info@aua.am END:VEVENT END:VCALENDAR